EXAS vs FLEX · rev $2.76B vs P/E 23, rev $6.40B
EXACT Sciences Corporation (EXAS) versus Flex Ltd (FLEX) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Flex Ltd (FLEX) is a electronic components company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
EXAS currently screens at market cap $20.03B. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Not investment advice. Open the EXAS and FLEX stock pages for the full models.
Not investment advice.